Pharmaceuticals & Drugs
|Market Cap||241 Cr||EPS||1.5||High||103.2|
|Stock P/E||66.0||Net Profit Margin||4.6||Low||98.15|
|Market Cap||241 Cr||ROE||-25.4%|
|P/B Ratio||3.7||Dividend Yield||0.0%|
|Industry P/E||65.5||Book Value||27.8|
About the Company
Bafna Pharmaceuticals was incepted by Bafna Mahaveer Chand in 1981 as a proprietary concern. It was converted into a public limited company on 28th march 1995. The company started its own manufacturing unit in October 1984.
Bafna Pharmaceuticals started its production with tablets facility and subsequently added capsule and oral syrup facilities respectively. BAFNA always focused on institutional and generic supply to keep its production line busy. It also concentrated on registering its products in the international market.
The present manufacturing facilities of BAFNA is set up at Chennai. The facility for producing Betalactam products was constructed in the year 2001 in a separate block.
It acquired 2.65 acres of factory land in Grantylon village, near Chennai to expand its operations to regulated market like US and
The company’s vision is to become a leading professionally run global pharma company setting standards across the pharma value chain.
|Parent Organisation||Bafna Pharmaceuticals Ltd.||Managing Director|
All values are in Rs Cr
|Company||52 Week||Market Price||P/E Ratio|
Frequently asked questions